{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:13:10Z","timestamp":1785510790862,"version":"3.56.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008100","name":"Southern University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008100","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.phymed.2026.158503","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:37:37Z","timestamp":1782625057000},"page":"158503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Epigallocatechin gallate targets the hexokinase 2\u2013voltage-dependent anion channel 1 axis in myofibroblasts to attenuate pulmonary fibrosis"],"prefix":"10.1016","volume":"159","author":[{"given":"Qi","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaipeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6474-9198","authenticated-orcid":false,"given":"Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phymed.2026.158503_bib0001","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00335-024-10069-w","article-title":"Identifying new molecular signatures and potential therapeutics for idiopathic pulmonary fibrosis: a network medicine approach","volume":"35","author":"Akca","year":"2024","journal-title":"Mamm. Genome."},{"issue":"1","key":"10.1016\/j.phymed.2026.158503_bib0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s43556-024-00240-9","article-title":"Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies","volume":"5","author":"Alam","year":"2024","journal-title":"Mol. Biomed."},{"issue":"18","key":"10.1016\/j.phymed.2026.158503_bib0003","doi-asserted-by":"crossref","first-page":"e183970","DOI":"10.1172\/JCI183970","article-title":"Teatime: epigallocatechin gallate targets fibroblast-epithelial cell crosstalk to combat lung fibrosis","volume":"134","author":"Burgy","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phymed.2026.158503_bib0004","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/molecules30030654","article-title":"Epigallocatechin gallate (EGCG): pharmacological properties, biological activities and therapeutic potential","volume":"30","author":"Capasso","year":"2025","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.phymed.2026.158503_bib0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/thoraxjnl-2019-213571","article-title":"GLUT1-dependent glycolysis regulates exacerbation of fibrosis via AIM2 inflammasome activation","volume":"75","author":"Cho","year":"2020","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.phymed.2026.158503_bib0006","doi-asserted-by":"crossref","first-page":"e49117","DOI":"10.15252\/embr.201949117","article-title":"Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca (2+) -dependent death of cancer cells","volume":"21","author":"Ciscato","year":"2020","journal-title":"EMBO Rep."},{"issue":"18","key":"10.1016\/j.phymed.2026.158503_bib0007","doi-asserted-by":"crossref","first-page":"e174598","DOI":"10.1172\/JCI174598","article-title":"A fibroblast-dependent TGF-\u03b21\/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosis","volume":"134","author":"Cohen","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"Pt A","key":"10.1016\/j.phymed.2026.158503_bib0008","article-title":"Saikosaponin C ameliorates renal injury and fibrosis via suppression of the HK2\/PKM2\/LDHA signaling mediated glycolysis in CKD","volume":"353","author":"Deng","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158503_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/biom14010031","article-title":"Loss of the DYRK1A protein kinase results in the reduction in ribosomal protein gene expression, ribosome mass and reduced translation","volume":"14","author":"Di Vona","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.phymed.2026.158503_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155807","article-title":"Therapeutic effects of flavonoids on pulmonary fibrosis: a preclinical meta-analysis","volume":"132","author":"Geng","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.phymed.2026.158503_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2023.100077","article-title":"Hexokinases in cancer and other pathologies","volume":"2","author":"Guo","year":"2023","journal-title":"Cell Insight"},{"issue":"4","key":"10.1016\/j.phymed.2026.158503_bib0012","doi-asserted-by":"crossref","first-page":"790","DOI":"10.7150\/ijms.105553","article-title":"The role of HK2 in tumorigenesis and development: potential for targeted therapy with natural products","volume":"22","author":"He","year":"2025","journal-title":"Int. J. Med. Sci."},{"issue":"8","key":"10.1016\/j.phymed.2026.158503_bib0013","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tem.2021.05.003","article-title":"The emerging role of metabolism in fibrosis","volume":"32","author":"Henderson","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.phymed.2026.158503_bib0014","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","article-title":"The safety of green tea and green tea extract consumption in adults - results of a systematic review","volume":"95","author":"Hu","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158503_bib0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41420-024-02078-0","article-title":"Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges","volume":"10","author":"Hu","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.phymed.2026.158503_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115111","article-title":"Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy","volume":"202","author":"Jin","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.phymed.2026.158503_bib0017","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s40203-024-00201-8","article-title":"Abatement of the binding of human hexokinase II enzyme monomers by in-silico method with the design of inhibitory peptides","volume":"12","author":"Karamifard","year":"2024","journal-title":"In Silico Pharmacol."},{"issue":"10","key":"10.1016\/j.phymed.2026.158503_bib0018","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00228-024-03720-7","article-title":"Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"80","author":"Kou","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.phymed.2026.158503_bib0019","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3390\/biomedicines13112679","article-title":"Reversal of myofibroblast apoptosis resistance and collagen deposition by phaseoloidin-induced autophagy attenuates pulmonary fibrosis","volume":"13","author":"Li","year":"2025","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.phymed.2026.158503_bib0020","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.cmet.2019.01.011","article-title":"Systematic dissection of the metabolic-apoptotic interface in AML reveals heme biosynthesis to be a regulator of drug sensitivity","volume":"29","author":"Lin","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2026.158503_bib0021","doi-asserted-by":"crossref","first-page":"0146","DOI":"10.34133\/research.0146","article-title":"Magnetic fields reduce apoptosis by suppressing phase separation of Tau-441","volume":"6","author":"Lin","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.phymed.2026.158503_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2023.07.003","article-title":"Glycolytic reprogramming in organ fibrosis: new dynamics of the epigenetic landscape","volume":"207","author":"Liu","year":"2023","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.phymed.2026.158503_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1586197","article-title":"Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland","volume":"16","author":"Majewski","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.phymed.2026.158503_bib0024","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.3390\/ijms24076737","article-title":"p53 and myofibroblast apoptosis in organ fibrosis","volume":"24","author":"Mcelhinney","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.phymed.2026.158503_bib0025","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3390\/antiox11081566","article-title":"Green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG): a time for a new player in the treatment of respiratory diseases?","volume":"11","author":"Mokra","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.phymed.2026.158503_bib0026","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/ijms24010340","article-title":"Therapeutic effects of green tea polyphenol (\u2012)-epigallocatechin-3-gallate (EGCG) in relation to molecular pathways controlling inflammation, oxidative stress, and apoptosis","volume":"24","author":"Mokra","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phymed.2026.158503_bib0027","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phymed.2026.158503_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1609509","article-title":"Revisiting pulmonary fibrosis: inflammatory dynamics of the lipofibroblast-to-inflammatory lipofibroblast-to-activated myofibroblast reversible switch","volume":"16","author":"Panagiotidis","year":"2025","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.phymed.2026.158503_bib0029","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.phymed.2026.158503_bib0030","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00018-022-04389-w","article-title":"Restricting \u03b1-synuclein transport into mitochondria by inhibition of \u03b1-synuclein-VDAC complexation as a potential therapeutic target for Parkinson's disease treatment","volume":"79","author":"Rajendran","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.phymed.2026.158503_bib0031","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cmet.2023.06.013","article-title":"Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis","volume":"35","author":"Rho","year":"2023","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.phymed.2026.158503_bib0032","doi-asserted-by":"crossref","first-page":"a041231","DOI":"10.1101\/cshperspect.a041231","article-title":"The role of myofibroblasts in physiological and pathological tissue repair","volume":"15","author":"Schuster","year":"2023","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"697","key":"10.1016\/j.phymed.2026.158503_bib0033","doi-asserted-by":"crossref","first-page":"eaay1027","DOI":"10.1126\/scisignal.aay1027","article-title":"Fibrometabolism-an emerging therapeutic frontier in pulmonary fibrosis","volume":"14","author":"Selvarajah","year":"2021","journal-title":"Sci. Signal."},{"issue":"2","key":"10.1016\/j.phymed.2026.158503_bib0034","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpha.2023.09.008","article-title":"Tanshinone IIA ameliorates energy metabolism dysfunction of pulmonary fibrosis using 13C metabolic flux analysis","volume":"14","author":"Shan","year":"2024","journal-title":"J. Pharm. Anal."},{"issue":"9","key":"10.1016\/j.phymed.2026.158503_bib0035","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1016\/j.drudis.2022.05.017","article-title":"The development of small-molecule inhibitors targeting hexokinase 2","volume":"27","author":"Shan","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.phymed.2026.158503_bib0036","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41467-021-22163-7","article-title":"SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis","volume":"12","author":"Shangguan","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.phymed.2026.158503_bib0037","doi-asserted-by":"crossref","first-page":"14229","DOI":"10.1111\/acel.14229","article-title":"A novel senolytic drug for pulmonary fibrosis: BTSA1 targets apoptosis of senescent myofibroblasts by activating BAX","volume":"23","author":"Shen","year":"2024","journal-title":"Aging Cell"},{"issue":"8","key":"10.1016\/j.phymed.2026.158503_bib0038","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/1440-1681.12428","article-title":"Epigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF-\u03b21 signalling","volume":"42","author":"Sriram","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"9","key":"10.1016\/j.phymed.2026.158503_bib0039","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/biom12091196","article-title":"Preventive effect of epigallocatechin gallate, the main component of green tea, on acute lung injury caused by air pollutants","volume":"12","author":"Tanaka","year":"2022","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.phymed.2026.158503_bib0040","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3390\/ijms20081958","article-title":"The effects of epigallocatechin gallate (EGCG) on pulmonary fibroblasts of idiopathic pulmonary fibrosis (IPF)-a next-generation sequencing and bioinformatic approach","volume":"20","author":"Tsai","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phymed.2026.158503_bib0041","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s40203-025-00404-7","article-title":"Computational assessment of natural compounds as potential hexokinase 2 inhibitors","volume":"13","author":"Uba","year":"2025","journal-title":"In Silico Pharmacol."},{"issue":"148","key":"10.1016\/j.phymed.2026.158503_bib0042","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0033-2018","article-title":"Matrix abnormalities in pulmonary fibrosis","volume":"27","author":"Upagupta","year":"2018","journal-title":"Eur. Respir. Rev.: An Official J. Eur. Resp. Iratory Soc."},{"issue":"3","key":"10.1016\/j.phymed.2026.158503_bib0043","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.201706-1301OC","article-title":"Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis. Results of the INJOURNEY trial","volume":"197","author":"Vancheri","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"17","key":"10.1016\/j.phymed.2026.158503_bib0044","doi-asserted-by":"crossref","first-page":"14824","DOI":"10.1021\/jacs.5c04233","article-title":"Inhibiting glycolysis and disrupting the mitochondrial HK2-VDAC1 protein-protein interaction using a bifunctional lonidamine-conjugated metal probe for combating triple-negative breast cancer","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.phymed.2026.158503_bib0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12951-021-01122-w","article-title":"Ceria nanoparticles ameliorate renal fibrosis by modulating the balance between oxidative phosphorylation and aerobic glycolysis","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.phymed.2026.158503_bib0046","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2174\/1871520623666221020092423","article-title":"Advances in the study of hexokinase 2 (HK2) inhibitors","volume":"23","author":"Wang","year":"2023","journal-title":"Anti-Cancer Agents Med. Chem."},{"issue":"6","key":"10.1016\/j.phymed.2026.158503_bib0047","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1039\/D3NR05487J","article-title":"Nanomedicines for targeted pulmonary delivery: receptor-mediated strategy and alternatives","volume":"16","author":"Wang","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.phymed.2026.158503_bib0048","doi-asserted-by":"crossref","first-page":"1379521","DOI":"10.3389\/fendo.2024.1379521","article-title":"Glycolysis and beyond in glucose metabolism: exploring pulmonary fibrosis at the metabolic crossroads","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158503_bib0049","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s44466-025-00002-4","article-title":"Lithium carbonate induces myofibroblast necroptosis to reverse pulmonary fibrosis","volume":"1","author":"Wei","year":"2025","journal-title":"Immun. Inflamm."},{"issue":"49","key":"10.1016\/j.phymed.2026.158503_bib0050","doi-asserted-by":"crossref","first-page":"41803","DOI":"10.1021\/acsnano.5c15619","article-title":"Engineering of metal-organic networks as band-aid for the repair of osteoporotic bone fractures","volume":"19","author":"Wei","year":"2025","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.phymed.2026.158503_bib0051","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acs.jnatprod.9b00949","article-title":"Scientific and regulatory approach to botanical drug development: A U.S. FDA perspective","volume":"83","author":"Wu","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.phymed.2026.158503_bib0052","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/ijms25010315","article-title":"Glycolysis reprogramming in idiopathic pulmonary fibrosis: unveiling the mystery of lactate in the lung","volume":"25","author":"Yan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158503_bib0053","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3892\/ijmm.2014.1745","article-title":"The green tea extract epigallocatechin-3-gallate inhibits irradiation-induced pulmonary fibrosis in adult rats","volume":"34","author":"You","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"8","key":"10.1016\/j.phymed.2026.158503_bib0054","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41580-024-00716-0","article-title":"Fibroblast and myofibroblast activation in normal tissue repair and fibrosis","volume":"25","author":"Younesi","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158503_bib0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pccm.2024.08.003","article-title":"Understanding myofibroblast origin in the fibrotic lung","volume":"2","author":"Zabihi","year":"2024","journal-title":"Chin. Med. J. Pulm. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.phymed.2026.158503_bib0056","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.ymthe.2025.12.013","article-title":"Methylated circPTK2 as a driver of fibroblast activation in pulmonary fibrosis","volume":"34","author":"Zhu","year":"2026","journal-title":"Mol. Ther."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326007348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326007348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:50:19Z","timestamp":1785509419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326007348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":56,"alternative-id":["S0944711326007348"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158503","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin gallate targets the hexokinase 2\u2013voltage-dependent anion channel 1 axis in myofibroblasts to attenuate pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"158503"}}